AFFLUENT MEDICAL |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.78 EUR | +4.09% |
|
+3.49% | -3.52% |
| Apr. 25 | Affluent Medical SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 13 | AFFLUENT MEDICAL : Invest Securities reiterates its opinion | CF |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Capitalization 1 | 63.81 | 63.81 | - |
| Enterprise Value (EV) 2 | 62.92 | 93.38 | 111.9 |
| P/E ratio | -3.42 x | -3.2 x | -1.95 x |
| Yield | - | - | - |
| Capitalization / Revenue | - | - | - |
| EV / Revenue | - | - | - |
| EV / EBITDA | -4.52 x | -6.14 x | -4.13 x |
| EV / FCF | -5.44 x | -5.45 x | -4.11 x |
| FCF Yield | -18.4% | -18.3% | -24.4% |
| Price to Book | 1.8 x | 3.64 x | - |
| Nbr of stocks (in thousands) | 33,145 | 33,145 | - |
| Reference price 3 | 1.710 | 1.710 | 1.710 |
| Announcement Date | 4/25/24 | - | - |
1EUR in Million2USD in Million3EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net sales 1 | - | - | - | - |
| EBITDA 1 | - | -13.91 | -15.21 | -27.12 |
| EBIT 1 | - | -16.49 | -17.72 | -29 |
| Operating Margin | - | - | - | - |
| Earnings before Tax (EBT) 1 | -16.79 | -16.93 | -18.15 | -39.71 |
| Net income 1 | -16.61 | -16.77 | -19.16 | -29.93 |
| Net margin | - | - | - | - |
| EPS 2 | - | -0.5400 | -0.5350 | -0.8750 |
| Free Cash Flow 1 | - | -13.69 | -17.13 | -27.24 |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 3/30/23 | 4/25/24 | - | - |
1USD in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Debt 1 | - | 10.7 | 29.6 | 48 |
| Net Cash position 1 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | -0.8213 x | -1.944 x | -1.772 x |
| Free Cash Flow 1 | - | -13.7 | -17.1 | -27.2 |
| ROE (net income / shareholders' equity) | - | -46.7% | -106% | - |
| ROA (Net income/ Total Assets) | - | - | - | - |
| Assets 1 | - | - | - | - |
| Book Value Per Share 2 | - | 0.9500 | 0.4700 | - |
| Cash Flow per Share 2 | - | -0.5500 | -0.4800 | -1.100 |
| Capex 1 | - | 0.07 | 0.82 | 1.07 |
| Capex / Sales | - | - | - | - |
| Announcement Date | 3/30/23 | 4/25/24 | - | - |
1USD in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.71
EUR
Average target price
3.367
EUR
Spread / Average Target
+96.88%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -3.52% | 61.3M | |
| +75.69% | 12.57B | |
| -25.26% | 7.42B | |
| +7.63% | 6.74B | |
| +12.43% | 5.34B | |
| -15.78% | 4.78B | |
| +28.18% | 4.62B | |
| -24.82% | 3.69B | |
| -21.90% | 2.9B | |
| +49.20% | 2.37B |
- Stock Market
- Equities
- AFME Stock
- Financials Affluent Medical
